Almirall and Shenzhen CrystalO Biopharma Technology have entered into a collaboration and licensing agreement to advance AI- and structure-based drug discovery for medical dermatology....
Almirall obtains exclusive global rights to develop and commercialize NN-8828 for use in several fields, including immune inflammatory dermatological diseases
Almirall S.A., a global pharmaceutical...